Larry B. Levy

1.6k total citations
15 papers, 1.2k citations indexed

About

Larry B. Levy is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Larry B. Levy has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 3 papers in Surgery. Recurrent topics in Larry B. Levy's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Larry B. Levy is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (10 papers) and Advanced Radiotherapy Techniques (8 papers). Larry B. Levy collaborates with scholars based in United States and Switzerland. Larry B. Levy's co-authors include Deborah A. Kuban, Anthony L. Zietman, Thomas M. Pisansky, Michael J. Zeléfsky, Eric M. Horwitz, Howard D. Thames, Patrick A. Kupelian, Alvaro A. Martinez, William U. Shipley and Brian J. Moran and has published in prestigious journals such as The Journal of Urology, International Journal of Radiation Oncology*Biology*Physics and Urology.

In The Last Decade

Larry B. Levy

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry B. Levy United States 12 1.0k 441 176 162 112 15 1.2k
Alan Pollack United States 16 972 0.9× 466 1.1× 258 1.5× 134 0.8× 178 1.6× 19 1.3k
Alessandra Siegmann Germany 14 1.0k 1.0× 339 0.8× 183 1.0× 216 1.3× 93 0.8× 25 1.1k
Chakiath Jose New Zealand 7 1.1k 1.1× 765 1.7× 144 0.8× 76 0.5× 188 1.7× 9 1.2k
André‐Guy Martin Canada 19 774 0.7× 504 1.1× 148 0.8× 67 0.4× 176 1.6× 90 1.0k
Marie Duclos Canada 21 1.0k 1.0× 640 1.5× 243 1.4× 75 0.5× 283 2.5× 85 1.4k
Daphna Y. Spiegel United States 8 605 0.6× 339 0.8× 375 2.1× 59 0.4× 77 0.7× 24 997
Mitchell Liu Canada 22 1.2k 1.1× 805 1.8× 278 1.6× 90 0.6× 415 3.7× 70 1.5k
Rachel C. Morgan United Kingdom 7 936 0.9× 625 1.4× 113 0.6× 55 0.3× 186 1.7× 12 1.1k
Joelle Helou Canada 18 821 0.8× 602 1.4× 121 0.7× 69 0.4× 280 2.5× 76 1.1k
Mihai Ghilezan United States 11 564 0.5× 443 1.0× 151 0.9× 66 0.4× 125 1.1× 14 866

Countries citing papers authored by Larry B. Levy

Since Specialization
Citations

This map shows the geographic impact of Larry B. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry B. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry B. Levy more than expected).

Fields of papers citing papers by Larry B. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry B. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry B. Levy. The network helps show where Larry B. Levy may publish in the future.

Co-authorship network of co-authors of Larry B. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Larry B. Levy. A scholar is included among the top collaborators of Larry B. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry B. Levy. Larry B. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tang, Chad, Michael S. Lee, Daniel R. Gomez, et al.. (2015). Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non–Small Cell Lung Cancer. American Journal of Clinical Oncology. 40(6). 625–630. 12 indexed citations
2.
Thames, Howard D., Deborah Kuban, Larry B. Levy, et al.. (2010). The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiotherapy and Oncology. 96(1). 6–12. 83 indexed citations
3.
Thames, Howard D., Deborah A. Kuban, Michelle DeSilvio, et al.. (2006). Increasing external beam dose for T1–T2 prostate cancer: Effect on risk groups. International Journal of Radiation Oncology*Biology*Physics. 65(4). 975–981. 16 indexed citations
4.
Zeléfsky, Michael J., Deborah A. Kuban, Larry B. Levy, et al.. (2006). Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation. International Journal of Radiation Oncology*Biology*Physics. 67(2). 327–333. 354 indexed citations
5.
Ray, Michael E., Larry B. Levy, Eric M. Horwitz, et al.. (2006). Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology. 68(6). 1257–1262. 23 indexed citations
6.
Kuban, Deborah A., Larry B. Levy, Louis Potters, et al.. (2006). Comparison of biochemical failure definitions for permanent prostate brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1487–1493. 91 indexed citations
7.
Lee, Andrew K., Larry B. Levy, Rex Cheung, & Deborah A. Kuban. (2005). Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy. International Journal of Radiation Oncology*Biology*Physics. 63(2). 456–462. 48 indexed citations
8.
Ray, Michael E., Howard D. Thames, Larry B. Levy, et al.. (2005). PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1140–1150. 140 indexed citations
9.
Horwitz, Eric M., Howard D. Thames, Deborah A. Kuban, et al.. (2005). DEFINITIONS OF BIOCHEMICAL FAILURE THAT BEST PREDICT CLINICAL FAILURE IN PATIENTS WITH PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION ALONE: A MULTI-INSTITUTIONAL POOLED ANALYSIS. The Journal of Urology. 173(3). 797–802. 103 indexed citations
10.
Chronowski, Gregory M., Richard B. Wilder, Larry B. Levy, et al.. (2004). Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease. American Journal of Clinical Oncology. 27(1). 73–80. 24 indexed citations
11.
Kuban, Deborah A., Howard D. Thames, & Larry B. Levy. (2004). PSA after radiation for prostate cancer.. PubMed. 18(5). 595–604; discussion 605, 609. 4 indexed citations
12.
Rosser, Charles J., Joel W. Slaton, Jonathan I. Izawa, Larry B. Levy, & Colin P. Dinney. (2003). Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults. Urology. 61(6). 1151–1155. 38 indexed citations
13.
Kuban, Deborah A., Howard D. Thames, Larry B. Levy, et al.. (2003). Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era. International Journal of Radiation Oncology*Biology*Physics. 57(4). 915–928. 216 indexed citations
14.
Kuban, Deborah A., Howard D. Thames, & Larry B. Levy. (2003). Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy. World Journal of Urology. 21(4). 253–264. 8 indexed citations
15.
Levy, Larry B., et al.. (2002). Loop Electrosurgical Excision Procedure in Vulvar Intraepithelial Neoplasia Treatment. Journal of Lower Genital Tract Disease. 6(4). 232–238. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Pollack Breakdown of academic impact, for papers by Alessandra Siegmann Breakdown of academic impact, for papers by Chakiath Jose Breakdown of academic impact, for papers by André‐Guy Martin Breakdown of academic impact, for papers by Marie Duclos Breakdown of academic impact, for papers by Daphna Y. Spiegel Breakdown of academic impact, for papers by Mitchell Liu Breakdown of academic impact, for papers by Rachel C. Morgan Breakdown of academic impact, for papers by Joelle Helou Breakdown of academic impact, for papers by Mihai Ghilezan
Rankless by CCL
2026